Angelini Pharmaceuticals Romania

Angelini Pharmaceutical Romania is active in Romania since 2011, even if  Angelini products (Tantum Verde, Trittico, Tantum Rosa) were present in the country since the nineties. It started as being represented by a small trading company Seder SRL, then as a CSC Representative office. After the acquisition by the Angelini Group in 2007, the transfer process has started and Angelini Romania became fully operative in 2011, when full portfolio and activities were transferred  to the new trading company.

Angelini is member of ARPIM, Romanian Association of Foreign Drug Manufacturer.

Angelini sells its products to major national wholesalers who distribute them to pharmacies and hospitals.

The main therapeutic areas of Angelini in Romania are: pain relief, respiratory, dermatology, gynecology, orthopedics, rheumatology, pediatrics, psychiatry and oncology.
In these areas Angelini is present with its products but the company is also an exclusive representative of many foreign pharmaceutical companies from France, Italy, Germany, Austria, Spain, Switzerland, USA, Great Britain and many others.

Angelini portfolio is composed of: ethic drugs (65%) and OTC (the most important OTC brand is Tantum Verde), food supplements and medical device .

Aulin Pain/Inflammation
Hyalgan (AH) Pain/Inflammation
Hyalone (AH) Pain/Inflammation
Hymovis (AH) Pain/Inflammation
Piascledine (ASU) Pain/Inflammation
Trittico CNS
Acutil CNS
Tantum Rosa Gynecology
Macmiror Complex Gynecology
Monural Gynecology
Feminella-Vagi C Gynecology
Feminella- Hyalosoft Gynecology
Feminella - Hereditum Gynecology
Dafnegin Gynecology
Iclusig Hematology
Xydalba Infectious disease
Aloxi Oncology - Biotech
Akynzeo Oncology - Biotech
Zibor Orthopedy - Surgery - ATI
Tantum Verde Respiratory Tract
Erdomed Respiratory Tract
Fluimucil Respiratory Tract
Kitonail Dermatology

Angelini Pharmaceutical Romania employs 87 people (66 in marketing and sales).

Angelini Pharmaceutical Romania holds the 17th  position in volume (with 7.8 M units) and the 25th in values in Romanian pharmaceutical market with an annual turnover of about 33 M€ (2015).